background methods cystic fibrosis growth lung function identified prognostic markers severity pulmonary disease survival studies patients cystic fibrosis cf including genotypes shown prepubertal patients lifetime continuous care specialised cf centre growth normalise corresponding improvement lung function used longitudinal design determine normalisation growth genetic subgroup prepubertal children cf homozygous delta f508 mutation known severe mutations methods data children born NUMBER homozygous delta f508 mutation diagnosed early childhood specialised centre childrens hospital berne systematically assessed age NUMBER years retrospectively analysed data height weight bmi compared swiss reference population using correlations lung function parameters fev1 mef50 vc age lung function parameters growth indices calculated additionally correlations examined cohort mutation born NUMBER years earlier results study cohort growth height weight bmi significantly normal swiss population significant decline lung function age association lung function growth seen compared earlier cohort improved growth decade shown improvement lung function detected lung function varied widely groups conclusion contrast sequential studies children cf present longitudinal study children homozygous delta f508 mutation failed confirm normalisation growth time compared data children born previous decade improved growth observed cross sectional follow z scores cross sectional